ECO ANIMAL HEALTH GROUP PLC

Director's Dealing • Dec 4, 2025

National Storage Mechanism | Additional information

RNS Number : 3252K

Eco Animal Health Group PLC

04 December 2025

04 December 2025

ECO Animal Health Group plc

("ECO" or the "Company")

Share Purchase by Executive Director

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that on 04 December 2025 David Hallas, Chief Executive Officer, purchased 18,348 ordinary shares in the Company ("Ordinary Shares") at 109 pence per Ordinary Share. Following this, Mr Hallas holds 203,041 Ordinary Shares, representing approximately 0.29 per cent. of the Company's issued share capital.

-Ends-

For further information please contact:

ECO Animal Health Group plc David Hallas (Chief Executive Officer) Christopher Wilks (Chief Financial Officer)	020 8447 8899
ICR Healthcare (Financial PR) Mary-Jane Elliott Jessica Hodgson	020 3709 5700
Singer Capital Markets (Nominated Adviser & Joint Broker) Philip Davies Sam Butcher Samed Ethemi	020 7496 3000
Panmure Liberum (Joint Broker) Emma Earl Will Goode Mark Rogers Rupert Dearden	020 3100 2000
Equity Development Hannah Crowe Matt Evans	020 7065 2692

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

PDMR Notification

1.           

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

David Hallas

2.            

Reason for the notification

a.            

Position/status

Chief Executive Officer

b.            

Initial notification

/Amendment

Initial notification

3.            

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Eco Animal Health Group Plc

b.           

LEI

2138009XN9DJ3YP70B55

4.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.            

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

GB0032036807

b.            

Nature of the transaction

Purchase of Ordinary Shares

c.            

Price(s) and volume(s)

Price(s)	Volume(s)
109p	18,348

d.            

Aggregated information

Aggregated volume

Price 

n/a

e.            

Date of the transaction

04 December 2025

f.            

Place of the transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBSBDDSGGDGUS